Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasma.

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Complexes between factor XI (FXI) and ADAMTS13 have been reported.
• A commercial ADAMTS13/FXI ELISA kit reportedly detects these complexes in plasma.
• Reduced levels of these complexes are observed in thrombotic thrombocytopenic purpura (TTP).

Purpose of the Study:

• To investigate the presence and significance of factor XI and ADAMTS13 complexes in plasma.
• To validate the findings of a commercial ADAMTS13/FXI ELISA kit.
• To determine the functional relevance of these complexes in hemostasis and TTP.

Main Methods:

• Utilized a commercial ADAMTS13/FXI ELISA kit to analyze plasma samples.
• Performed experiments with mixtures of recombinant ADAMTS13 and FXI.
• Employed immunoprecipitation and gel filtration chromatography to detect complexes.

Main Results:

• The commercial ELISA kit detected variable signal in control and TTP patient plasma.
• No signal was observed when mixing recombinant ADAMTS13 and FXI, indicating minimal interaction.
• Immunoprecipitation and gel filtration chromatography failed to detect ADAMTS13/FXI complexes in plasma or recombinant mixtures.

Conclusions:

• ADAMTS13/FXI complexes are insignificant in plasma.
• The detected signal in the commercial ELISA kit may not represent true biological complexes.
• These complexes are unlikely to play a functional role in normal hemostasis or TTP.